Skip to content

ELOX — Eloxx Pharmaceuticals Inc Institutional Holders · Q2 2026

Who owns Eloxx Pharmaceuticals Inc (ELOX)? 20 institutions reported holding $34.70M in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Nantahala Capital Management, LLC ($5.6M), EcoR1 Capital, LLC ($5.6M), Aberdeen Group plc ($5.6M).

RankInstitutionValueSharesChange
1Nantahala Capital Management, LLC$5.6M400,000New
2EcoR1 Capital, LLC$5.6M400,000New
3Aberdeen Group plc$5.6M400,000New
4SAMSARA BIOCAPITAL, LLC$5.6M400,000New
5Siren, L.L.C.$5.6M400,000New
6Stonepine Capital Management, LLC$5.5M397,160New
7VANGUARD GROUP INC$1.2M90,000New
8SEVEN GRAND MANAGERS, LLC$138,80010,000New
9MORGAN STANLEY$21,4311,544New
10UBS Group AG$8,842637New
11WELLS FARGO & COMPANY/MN$1,749126New
12Pioneer Family Office, LLC$1,33296New
13Royal Bank of Canada$1,00098New
14Altshuler Shaham Ltd$34725New
15BARCLAYS PLC$16712New
16OLD POINT TRUST & FINANCIAL SERVICES N A$695New
17Activest Wealth Management$564New
18CITIGROUP INC$564New
19SBI Securities Co., Ltd.$282New
20Point Nemo Capital, LLC$141New

Source: SEC Form 13F filings · as of 2026-06-30